Green Vision Biotechnology. Revenue Growth Rates (GVBT), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Green Vision Biotechnology Corp.  (GVBT)
 

GVBT's Revenue Growth by Quarter and Year

Green Vision Biotechnology.'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GVBT Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.00
1st Quarter March 0.00
FY 0.00

GVBTs Annual Revenue
Green Vision Biotechnology.'s Revenue in the fiscal year 2021 $ 0.15 millions
Green Vision Biotechnology.'s Revenue in the fiscal year 2020 $ 0.09 millions
Green Vision Biotechnology.'s Revenue in the fiscal year 2019 $ 0.08 millions
Green Vision Biotechnology.'s Revenue in the fiscal year 2018 $ 0.10 millions
Green Vision Biotechnology.'s Revenue in the fiscal year 2017 $ 0.14 millions




GVBT Revenue second quarter 2021 Y/Y Growth Comment
Green Vision Biotechnology Corp. in the second quarter 2021 recorded of $ 0.00 millions.

According to the results reported in the second quarter 2021, Green Vision Biotechnology Corp. achieved the best Revenue growth in Agricultural Production industry. While Green Vision Biotechnology Corp.' s Revenue meltdown of -100% ranks overall at the positon no. in the second quarter 2021.


GVBT Revenue ( Y/Y Growth %) 2021
 2020 2019 2018
4th Quarter December - - - -
3rd Quarter September - - 0 % -
2nd Quarter June - 166.67 % -25 % 33.33 %
1st Quarter March - 50 % 33.33 % -40 %
FY   - 55.56 % 12.5 % -

Financial Statements
Green Vision Biotechnology.'s second quarter 2021 Revenue $ 0.00 millions GVBT's Income Statement
Green Vision Biotechnology.'s second quarter 2020 Revenue $ 0.08 millions Quarterly GVBT's Income Statement


GVBT Revenue (Quarter on Quarter Growth %)

 2021
 2020 2019 2018
4th Quarter December - - 0 % -
3rd Quarter September - - -66.67 % -75 %
2nd Quarter June - 33.33 % -25 % 33.33 %
1st Quarter March - 500 % - 200 %
FY (Year on Year)   - 55.56 % 12.5 % -


Back to GVBT Growth rate Comparisons >> Back to GVBT Growth rate Comparisons >>


Revenue second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Agricultural Production Industry #
Consumer Non Cyclical Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
(Jun 30 2021)   (Mar 31 2019)
Revenue second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Agricultural Production Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
(Jun 30 2021)   (Mar 31 2019)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Green Vision Biotechnology.'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GVBT's II. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Agricultural Production Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Agricultural Production Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GVBT's II. Quarter Q/Q Revenue Comment


Green Vision Biotechnology.'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2022)		 12 Months Ending
(Mar 31 2022)		 12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Sep 30 2021)		 12 Months Ending
(Jun 30 2021)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.16
Y / Y Revenue Growth (TTM) - - - - 117.71 %
Year on Year Revenue Growth Overall Ranking # 304 # 0 # 0 # 0 # 245
Seqeuential Revenue Change (TTM) - - - - 47.72 %
Seq. Revenue Growth (TTM) Overall Ranking # 819 # 0 # 0 # 0 # 159


Cumulative Revenue growth Comment
Green Vision Biotechnology Corp. realized trailing twelve months of $ 0 millions, in the Jun 30 2022, compare to Revenue of $ 0 millions a year ago.

Among companies within the Consumer Non Cyclical sector 9 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 304.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Agricultural Production Industry # 9
Consumer Non Cyclical Sector # 10
Overall # 304

Revenue TTM Y/Y Growth Statistics
High Average Low
117.71 %
 -3.28 %
-59.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 30
S&P 500 # 819
Cumulative Revenue growth Comment
Green Vision Biotechnology Corp. realized trailing twelve months of $ 0 millions, in the Jun 30 2022, compare to Revenue of $ 0 millions a year ago.

Among companies within the Consumer Non Cyclical sector 9 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 304.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Agricultural Production Industry # 9
Consumer Non Cyclical Sector # 10
Overall # 304

Revenue TTM Y/Y Growth Statistics
High Average Low
117.71 %
-3.28 %
-59.31 %
 






Other Revenue Growth
Agricultural Production Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
GVBT's Revenue Growth Ratio versus Agricultural Production Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue meltdown for the quarter ending Jun 30 2022 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Jun 30 2022
The Clorox Company-0.06%$ -0.055 millions
Philip Morris International Inc -0.06%$ -0.059 millions
United guardian Inc -0.87%$ -0.869 millions
Kraft Heinz Co-0.92%$ -0.922 millions
Fitlife Brands Inc -1.74%$ -1.744 millions
Central Garden and Pet Company-2.09%$ -2.092 millions
Willamette Valley Vineyards Inc -2.78%$ -2.783 millions
Ocean Bio chem Inc-3.06%$ -3.060 millions
Tingo Group Inc -3.10%$ -3.103 millions
Niagen Bioscience Inc -5.46%$ -5.464 millions
Altria Group Inc -5.67%$ -5.666 millions
Laird Superfood Inc -5.67%$ -5.674 millions
Pacific Ventures Group Inc -9.04%$ -9.041 millions
Est e Lauder Companies Inc-9.53%$ -9.527 millions
Revlon Inc -11.02%$ -11.017 millions
Equator Beverage Company-11.91%$ -11.913 millions
S and w Seed Co-12.13%$ -12.129 millions
Turning Point Brands Inc -16.08%$ -16.078 millions
Nocera Inc -16.80%$ -16.797 millions
Natural Health Trends Corp -17.29%$ -17.286 millions
Mannatech Inc-17.71%$ -17.711 millions
Cbdmd Inc -18.63%$ -18.632 millions
Twinlab Consolidated Holdings Inc -20.08%$ -20.078 millions
Canopy Growth Corporation-20.95%$ -20.950 millions
Avon Products Inc -22.22%$ -22.225 millions
Mediwound Ltd -22.93%$ -22.932 millions
Chase General Corp-23.49%$ -23.486 millions
Cirtran Corporation-24.80%$ -24.796 millions
Alico Inc -25.65%$ -25.654 millions
Hydrofarm Holdings Group Inc -27.12%$ -27.124 millions


About Green Vision Biotechnology. Revenue Growth Rates (GVBT), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Green Vision Biotechnology Corp (CIK 1571804).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001640334-22-002058
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Green Vision Biotechnology Corp ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.